Consent in elective joint replacement surgery: are we doing enough?

Clinical Risk ◽  
2007 ◽  
Vol 13 (4) ◽  
pp. 131-132
Author(s):  
Atif Waheed ◽  
Kamran Ahmed ◽  
Sameh Ansara ◽  
Shivanand S Geeranavar

A substantial number of clinical negligence claims arise from a failure to adequately advise patients prior to surgery. It is important for surgeons at all levels to maintain good practice in obtaining consent and to recognize that the standards against which they are judged in litigation have changed in recent years. Consent is a process rather than an event and evidence of valid consent includes the surgeon's letters, oral and written information given to the patient and, to a limited extent, the consent form. We retrospectively audited the documentation relating to consent in the case notes of 50 patients undergoing elective joint replacement surgery between August 2004 and March 2005, and found that documentation was generally inadequate. We recommend that there should be national guidance on complications for standard elective joint replacement procedures. This could be incorporated into the best practice guidance on joint replacement surgery published by the British Orthopaedic Association.

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Marco S. Caicedo ◽  
Vianey Flores ◽  
Alicia Padilla ◽  
Samelko Lauryn ◽  
Joshua J. Jacobs ◽  
...  

Abstract Background Recent studies indicate that, in addition to antibody production, lymphocyte responses to SARS-CoV-2 may play an important role in protective immunity to COVID-19 and a percentage of the general population may exhibit lymphocyte memory due to unknown/asymptomatic exposure to SARS-CoV-2 or cross-reactivity to other more common coronaviruses pre-vaccination. Total joint replacement (TJR) candidates returning to elective surgeries (median age 68 years) may exhibit similar lymphocyte and/or antibody protection to COVID-19 prior to vaccination Methods In this retrospective study, we analyzed antibody titters, lymphocyte memory, and inflammatory biomarkers specific for the Spike and Nucleocapsid proteins of the SARS-CoV-2 virus in a cohort of n=73 returning TJR candidates (knees and/or hips) pre-operatively. Results Peripheral blood serum of TJR candidate patients exhibited a positivity rate of 18.4% and 4% for IgG antibodies specific for SARS-CoV-2 nucleocapsid and spike proteins, respectively. 13.5% of TJR candidates exhibited positive lymphocyte reactivity (SI > 2) to the SARS-CoV-2 nucleocapsid protein and 38% to the spike protein. SARS-CoV-2 reactive lymphocytes exhibited a higher production of inflammatory biomarkers (i.e., IL-1β, IL-6, TNFα, and IL-1RA) compared to non-reactive lymphocytes. Conclusions A percentage of TJR candidates returning for elective surgeries exhibit pre-vaccination positive SARS-CoV-2 antibodies and T cell memory responses with associated pro-inflammatory biomarkers. This is an important parameter for understanding immunity, risk profiles, and may aid pre-operative planning. Trial registration Retrospectively registered.


2015 ◽  
Vol 68 (1) ◽  
pp. 73-79 ◽  
Author(s):  
David J. Beard ◽  
Kristina Harris ◽  
Jill Dawson ◽  
Helen Doll ◽  
David W. Murray ◽  
...  

2015 ◽  
Vol 42 ◽  
pp. S32
Author(s):  
J.E. Naili ◽  
A.C. Esbjörnsson ◽  
M.D. Iversen ◽  
M.H. Schwartz ◽  
C. Häger ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document